<DOC>
	<DOCNO>NCT02213783</DOCNO>
	<brief_summary>This prospective randomized study compare pharmacodynamics ( &gt; MIC ) 0.5 g every 6 h imipenem twelve patient febrile neutropenia follow administration 4 h infusion bolus injection . Concentration imipenem plasma measure HPLC method simulate Monte Carlo technique ( Computer model ) get PK/PD index ( 40 % T &gt; MIC ) report % PTA ( Probability Target Attainment ) % CFR ( Cumulative Faction Response .</brief_summary>
	<brief_title>Comparison Pharmacodynamics Imipenem Patients With Febrile Neutropenia</brief_title>
	<detailed_description />
	<mesh_term>Neutropenia</mesh_term>
	<mesh_term>Fever</mesh_term>
	<mesh_term>Febrile Neutropenia</mesh_term>
	<mesh_term>Imipenem</mesh_term>
	<criteria>Patients age &gt; = 20 year Patients febrile neutropenia Gram negative bacillus infection sensitive imipenem disk diffusion Patients likely survive 3 day Patients documented hypersensitivity imipenem carbapenems Patients estimate creatinine clearance &lt; 50 ml/min Patients circulatory shock hypotension ( systolic &lt; 90 mmHg ) Patients pregnant</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>Imipenem</keyword>
	<keyword>Febrile neutropenia</keyword>
	<keyword>Gram-negative infection</keyword>
	<keyword>Pharmacodynamic</keyword>
	<keyword>Monte Carlo Simulation</keyword>
</DOC>